Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Impact of Molecular Subtyping of Pancreatic Cancer

5 Nov 2021

Abstract excerpt

Pancreatic ductal adenocarcinoma is a highly lethal malignancy, which has now become the seventh most common cause of cancer death in the world, with the highest mortality rates in Europe and North America. In the past 30 years, there has been some progress in 5-year survival (rates increasing from 2.5 to 10%), but this is still extremely poor compared to all other common cancer types. Targeted therapies for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34805152
DOI: 10.3389/fcell.2021.743908

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Impact of Molecular Subtyping of Pancreatic CancerPMID 34805152Read ↗

Clinical utility of molecular subtyping of pancreatic cancerSemantic proximity Read ↗

Pancreatic Cancer Molecular Classifications: From Bulk Genomics to Single Cell AnalysisSemantic proximity Read ↗

The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectivesSemantic proximity Read ↗

Evidence for molecular subtyping in pancreatic ductal adenocarcinoma: a systematic review.Semantic proximity Read ↗

Basal‐like and classical cells coexist in pancreatic cancer revealed by single‐cell analysis on biopsy‐derived pancreatic cancer organoids from the classical subtypeSemantic proximity Read ↗

Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapySemantic proximity Read ↗

Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer.Semantic proximity Read ↗

Molecular and Phenotypic Profiling for Precision Medicine in Pancreatic Cancer: Current Advances and Future PerspectivesSemantic proximity Read ↗

Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance.Semantic proximity Read ↗

Deconstructing Pancreatic Cancer Using Next Generation-Omic Technologies–From Discovery to Knowledge-Guided Platforms for Better Patient ManagementSemantic proximity Read ↗

Genomic analyses identify molecular subtypes of pancreatic cancer.Semantic proximity Read ↗

Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.